Fate Therapeutics (FATE) Preferred Shares (2016 - 2026)
Fate Therapeutics' (FATE) quarterly Preferred Shares came in at $3000.0 in Q1 2026, little changed YoY from $3000.0 in Q1 2025, and little changed on a QoQ basis from $3000.0 in Q4 2025.
Fate Therapeutics (FATE) Preferred Shares (2016 - 2026) Analysis & Trends
Fate Therapeutics (FATE) has 11 years of Preferred Shares data on file, last reported at $3000.0 in Q1 2026.
- Quarterly Preferred Shares changed 0.0% year-over-year to $3000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3000.0 (changed 0.0% YoY) and the FY2025 annual result came in at $3000.0, changed 0.0% from the prior year.
- Preferred Shares was little changed at $3000.0 in Q1 2026, from $3000.0 in the prior quarter.
- In the past five years, Preferred Shares ranged from a high of $3000.0 in Q1 2022 to a low of $3000.0 in Q1 2022.
- A 5-year average of $3000.0 and a median of $3000.0 in 2022 frame the typical range for Preferred Shares.
- The widest YoY moves for Preferred Shares: up 0.0% in 2022, down 0.0% in 2022.
- Tracing FATE's Preferred Shares over 5 years: stood at $3000.0 in 2022, then changed by 0.0% to $3000.0 in 2023, then changed by 0.0% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025, then changed by 0.0% to $3000.0 in 2026.
- The last three Preferred Shares figures came in at $3000.0 (Q1 2026), $3000.0 (Q4 2025), and $3000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - | 3,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3,000.00 |
| Dec 31, 2025 | 3,000.00 |
| Sep 30, 2025 | 3,000.00 |
| Jun 30, 2025 | 3,000.00 |
| Mar 31, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | 3,000.00 |
| Sep 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 3,000.00 |
| Dec 31, 2022 | 3,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | 3,000.00 |
| Jun 30, 2021 | 3,000.00 |